AMETEK (NYSE:AME) Updates FY 2026 Earnings Guidance

AMETEK (NYSE:AME) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 7.870-8.070 for the period, compared to the consensus estimate of 8.000. The company issued revenue guidance of -. AMETEK also updated its Q1 2026 guidance to 1.850-1.900 EPS.

AMETEK Price Performance

Shares of NYSE:AME opened at $228.48 on Tuesday. The company’s fifty day moving average price is $208.39 and its 200-day moving average price is $194.48. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.16 and a quick ratio of 0.72. The firm has a market capitalization of $52.60 billion, a price-to-earnings ratio of 36.04, a PEG ratio of 3.05 and a beta of 1.03. AMETEK has a one year low of $145.02 and a one year high of $229.03.

AMETEK Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Friday, December 5th were issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Friday, December 5th. AMETEK’s dividend payout ratio is presently 19.56%.

Analyst Ratings Changes

A number of brokerages recently weighed in on AME. Barclays raised their price objective on AMETEK from $205.00 to $210.00 and gave the company an “equal weight” rating in a report on Wednesday, January 7th. Mizuho lifted their price target on shares of AMETEK from $225.00 to $230.00 and gave the stock an “outperform” rating in a research note on Monday, January 5th. Wall Street Zen upgraded shares of AMETEK from a “hold” rating to a “buy” rating in a report on Saturday, November 1st. KeyCorp increased their target price on shares of AMETEK from $220.00 to $235.00 and gave the company an “overweight” rating in a report on Tuesday, January 6th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of AMETEK in a research report on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, AMETEK presently has an average rating of “Moderate Buy” and a consensus price target of $229.82.

Insider Activity

In other news, insider Thomas C. Marecic sold 14,310 shares of AMETEK stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $202.11, for a total transaction of $2,892,194.10. Following the sale, the insider owned 42,589 shares of the company’s stock, valued at approximately $8,607,662.79. The trade was a 25.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Thomas M. Montgomery sold 6,388 shares of the company’s stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $205.05, for a total value of $1,309,859.40. Following the transaction, the vice president owned 22,116 shares in the company, valued at $4,534,885.80. This trade represents a 22.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 137,088 shares of company stock valued at $27,212,340. Insiders own 0.57% of the company’s stock.

Key Stories Impacting AMETEK

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Reported record fourth?quarter and full?year 2025 results, reinforcing underlying business strength. AMETEK Announces Record Fourth Quarter and Full Year Results
• Positive Sentiment: Completed acquisition of LKC Technologies (adds ophthalmic diagnostic capabilities), expanding AMETEK’s medical/diagnostics exposure and product portfolio. AMETEK Acquires LKC Technologies DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK
• Neutral Sentiment: Pre?earnings coverage and previews highlight improving process markets and set context for investor expectations ahead of management commentary. Ametek Earnings on Deck as Process Markets Show Signs of Life Ametek Q4 2025 Earnings Preview
• Negative Sentiment: Updated FY?2026 EPS guidance of $7.87–$8.07 is slightly below the consensus of $8.00, signaling more modest full?year growth than investors expected.
• Negative Sentiment: Q1?2026 EPS guidance of $1.85–$1.90 is at/just below the $1.90 consensus; revenue guidance centered around ~$1.9B also met modest expectations — collectively this conservative near?term outlook is pressuring the stock.
• Negative Sentiment: Giverny Capital trimmed its AMETEK position, citing valuation, which is a small negative signal about investor positioning. Giverny Capital Asset Management Trimmed Ametek (AME) on Valuation

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Darwin Wealth Management LLC purchased a new position in shares of AMETEK in the 2nd quarter worth $25,000. Johnson Financial Group Inc. lifted its holdings in AMETEK by 17.4% in the third quarter. Johnson Financial Group Inc. now owns 478 shares of the technology company’s stock valued at $90,000 after acquiring an additional 71 shares during the period. Advisory Services Network LLC purchased a new position in AMETEK in the third quarter worth about $92,000. MUFG Securities EMEA plc bought a new stake in shares of AMETEK during the 2nd quarter valued at about $123,000. Finally, Larson Financial Group LLC increased its position in shares of AMETEK by 19.4% during the 3rd quarter. Larson Financial Group LLC now owns 739 shares of the technology company’s stock valued at $139,000 after purchasing an additional 120 shares during the last quarter. Institutional investors own 87.43% of the company’s stock.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.